Search results for "Heterocyclic compound"

showing 10 items of 382 documents

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

2017

Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand therapy (PSMA-RLT) of prostate cancer as well as PET imaging when labeled with lutetium-177 and gallium-68 respectively. Considering the relatively short physical half-life of gallium-68 this positron emitter precludes prolonged acquisition periods, as required for pre-therapeutic dosimetry or intraoperative applications. In this context, the positron emitter scandium-44 is an attractive alternative for PET imaging. We report the synthesis of [44Sc…

OncologyMalemedicine.medical_specialtytheranostics.Medicine (miscellaneous)Context (language use)SpleenGallium RadioisotopesLutetiumurologic and male genital diseases030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerHeterocyclic Compounds 1-Ring0302 clinical medicineInternal medicinePositron Emission Tomography Computed TomographyLNCaPmedicineDosimetryHumansRadiometryPharmacology Toxicology and Pharmaceutics (miscellaneous)AgedRadioisotopesUrinary bladderChemistrybusiness.industryDipeptidesProstate-Specific Antigenmedicine.diseaseprostate cancerPSMA-617scandium-44Small intestineProstatic Neoplasms Castration-Resistantmedicine.anatomical_structurePET030220 oncology & carcinogenesisAbsorbed doseRadiopharmaceuticalsNuclear medicinebusinessScandiumResearch PaperHalf-LifeTheranostics
researchProduct

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer.

2021

To evaluate the cost-effectiveness of first-line treatments, such as erlotinib, gefitinib, afatinib, dacomitinib, and osimertinib, for patients diagnosed with stage IIIB/IV NSCLC harboring EGFR mutations.A partitioned survival model was developed to estimate quality-adjusted life-year (QALY) and incremental cost-effectiveness ratio (ICER) from the perspective of the Spanish National Health System. Two Bayesian NMAs were performed independently, by using the polynomial fraction method to fit Kaplan-Meier curves for overall survival and progression-free survival. Deterministic and probabilistic sensitivity analyses were performed to evaluate the uncertainty.The ICER was calculated for the fou…

Oncologycongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyLung NeoplasmsCost effectivenessAfatinibCost-Benefit AnalysisAfatinibchemistry.chemical_compoundErlotinib HydrochlorideGefitinibInternal medicineCarcinoma Non-Small-Cell LungmedicineHumansheterocyclic compoundsPharmacology (medical)OsimertinibLung cancerneoplasmsProtein Kinase Inhibitorsbusiness.industryHealth PolicyBayes TheoremGefitinibGeneral MedicineCost-effectiveness analysismedicine.diseaseDacomitinibrespiratory tract diseasesErbB ReceptorschemistryMutationErlotinibbusinessmedicine.drugExpert review of pharmacoeconomicsoutcomes research
researchProduct

A promising camptothecin derivative: Semisynthesis, antitumor activity and intestinal permeability.

2014

Oral administration of camptothecin (Cm) derivatives and other antitumoral agents is being actively developed in order to improve the quality of life of patients with cancer. Though several lipophilic derivatives of CPT have shown interesting oral bioavailability in preclinical and clinical studies, only Topotecan has been approved for this route of administration. Semisynthesis, antitumor activity, biological inhibition mechanism, and in situ intestinal permeability of 9, 10-[1,3]-Dioxinocamptothecin (CDiox), an unexplored CPT derivative, have been studied in this paper. The hexacyclic analog was as effective as Topotecan and CPT in different tumor cell lines, showing an expected similar a…

Oralendocrine system diseasesCellDioxinocamptothecinTransportAntineoplastic AgentsChemistry Techniques SyntheticPharmacologyPermeabilityHeLaQUIMICA ORGANICAPharmacokineticsOral administrationCell Line TumorDrug DiscoverymedicineAnimalsHumansheterocyclic compoundsIntestinal MucosaneoplasmsPharmacologybiologyChemistryOrganic ChemistryBiological TransportGeneral MedicineAntitumorbiology.organism_classificationSemisynthesisIn vitroRatsmedicine.anatomical_structureTopotecanCamptothecinCamptothecinmedicine.drugEuropean journal of medicinal chemistry
researchProduct

Triazolopyridines 20. Hydrogenation reactions

1999

Abstract Hydrogenation reactions of some [1,2,3]triazolo[1,5-a]pyridines and their benzo derivatives, [1,2,3]-triazolo[1,5-a]quinoline and [1,2,3]triazolo[5,1-a]isoquinoline are studied. In general, the pyridine ring is more easily hydrogenated than the triazole or benzene rings.

Organic ChemistryQuinolineTriazoleRing (chemistry)BiochemistryMedicinal chemistrychemistry.chemical_compoundchemistryDrug DiscoveryBicyclic Heterocyclic CompoundsPyridineOrganic chemistryIsoquinolineBenzeneTetrahedron
researchProduct

Room temperature ionic liquids structure and its effect on the mononuclear rearrangement of heterocycles: an approach using thermodynamic parameters.

2006

The kinetics of the rearrangement of the Z-phenylhydrazone of 3-benzoyl-5-phenyl-1,2,4-oxadiazole (1) into the relevant 4-benzoylamino-2,5-diphenyl-1,2,3-triazole (2) induced by amines have been studied in five room-temperature ionic liquids (RTILs) at different temperatures. The kinetic data collected show that both cationic and anionic parts of RTILs significantly influence the reactivity of the title reaction. The calculated activation parameters allow us to advance hypotheses about the weak interactions operating in RTIL solutions.

OxadiazolesMolecular StructureOrganic ChemistryKineticsCationic polymerizationHydrazonesTemperatureIonic Liquidsionic liquids base catalysis MHR reactionTriazolesKinetic energyIonchemistry.chemical_compoundchemistryHeterocyclic CompoundsIonic liquidOrganic chemistryPhysical chemistryMoleculeThermodynamicsReactivity (chemistry)Amine gas treatingAminesThe Journal of organic chemistry
researchProduct

Oxidative Coupling Reactions of 1,3-Diarylpropene Derivatives to Dibenzo[a,c]cycloheptenes by PIFA

2011

The oxidative cyclization reactions of a variety of α-benzyl-cinnamates can be selectively performed with hypervalent iodine as an oxidant. The dibenzo[a,c]cycloheptenes were isolated in up to 55 % yield. When an oxo substrate is applied, the yield was significantly increased. With this synthetic approach, a central intermediate for the synthesis of metasequirin-B was obtained in three steps from very simple starting materials. For this transformation, both aryl moieties have to be activated.

Oxidative cyclizationArylOrganic ChemistryHypervalent moleculefood and beveragesSubstrate (chemistry)chemistry.chemical_elementIodineMedicinal chemistrychemistry.chemical_compoundChemical couplingchemistryYield (chemistry)Organic chemistryheterocyclic compoundsOxidative coupling of methanePhysical and Theoretical ChemistryEuropean Journal of Organic Chemistry
researchProduct

In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi

2021

Recently, the first squaramide-(SA) containing FAP inhibitor-derived radiotracers were introduced. DATA5m.SA.FAPi and DOTA.SA.FAPi with their non-radioactive complexes showed high affinity and selectivity for FAP. After a successful preclinical study with [68Ga]Ga-DOTA.SA.FAPi, the first patient studies were realized for both compounds. Here, we present a new squaramide-containing compound targeting FAP, based on the AAZTA5 chelator 1,4-bis-(carboxylmethyl)-6-[bis-(carboxymethyl)-amino-6-pentanoic-acid]-perhydro-1,4-diazepine. For this molecule (AAZTA5.SA.FAPi), complexation with radionuclides such as gallium-68, scandium-44, and lutetium-177 was investigated, and the in vitro properties of…

PREPPharmaceutical ScienceAcetatesLutetiumLigands030218 nuclear medicine & medical imagingAnalytical ChemistrySerinechemistry.chemical_compoundQD241-4410302 clinical medicineFibroblast activation protein alphaPositron Emission Tomography Computed TomographyDrug Discoverylutetium-177AAZTA; scandium-44; lutetium-177; FAP; SA; DPP; PREPQuinineChemistrySerine EndopeptidasesAzepinesscandium-44ChemistryChemistry (miscellaneous)030220 oncology & carcinogenesisMolecular MedicineSelectivityDPPGallium RadioisotopesConjugated systemArticleHeterocyclic Compounds 1-Ring03 medical and health sciencesSAEndopeptidasesHumansDOTAChelationPhysical and Theoretical ChemistryBiologyAAZTARadioisotopesOrganic ChemistrySquaramideMembrane ProteinsFAPFibroblastsCombinatorial chemistryIn vitroRadiopharmaceuticalsScandiumMolecules
researchProduct

Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease

2016

Background: The treatment and diagnosis of Alzheimer’s Disease (AD) are two of the most urgent goals for research around the world. The cognitive decline is generally associated with the elevated levels of extracellular senile plaques, intracellular neurofibril- lary tangles (NFTs), and with a progressive shutdown of the cholinergic basal forebrain neurons transmission. Even if several key targets are under fervent investigation in the cure of AD, till now, the only approved therapeutic strategy is the treatment of symptoms by using cholinesterases inhibitors. It has been demonstrated that both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes are not only responsible of…

Pathologymedicine.medical_specialtyTau proteinDisease010402 general chemistry01 natural scienceschemistry.chemical_compoundAlzheimer DiseaseHeterocyclic CompoundsDrug DiscoverymedicineAnimalsHumansSenile plaquesCognitive declineButyrylcholinesterasePharmacologybiologyMolecular Structure010405 organic chemistryChemistryAcetylcholinesterase0104 chemical sciencesbiology.proteinCholinergicNeuroscienceAmyloid precursor protein secretaseAlzheimer’s disease amyloid-peptide secretase acetylcholinesterase tau protein heterocycles
researchProduct

Linezolidtherapie bei zwei Frühgeborenen mit nekrotisierender Enterokolitis und Infektion durch Vancomycin-resistente Enterokokken

2004

The use of the antibiotic Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus is described. Therapy with Linezolid in cause of necrotizing enterocolitis is an exception. Actually there are no proven recommendations for the use in this age group. Despite the successfully results more investigations for the use of linezolid in newborns and prematures are necessary.

Pediatricsmedicine.medical_specialtymedicine.drug_classAntibioticsDrug resistancemedicine.disease_causechemistry.chemical_compoundPharmacotherapymedicineheterocyclic compoundsVancomycin-resistant EnterococcusEnterocolitisbiologybusiness.industryorganic chemicalsbiochemical phenomena metabolism and nutritionbacterial infections and mycosesmedicine.diseasebiology.organism_classificationEnterococcuschemistryPediatrics Perinatology and Child HealthNecrotizing enterocolitisLinezolidbacteriamedicine.symptombusinessKlinische Pädiatrie
researchProduct

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

2015

Journal Article; Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through complex interventions. Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and so bone resorption. BPs are widely used, with many patients receiving continuous treatment for years. But it is well known that these drugs can produce osteonecrosis of the jaw (ONJ). Zoledronic acid (ZA) is an intravenous BP used in the treatment and prophylaxis of bone disease in patients with malignant tumors with bone implication. ZA is the most potent BP in clinical development. This report describes the case of a 62-year-old woman with breast cancer antecedents which…

Peri-implantitisBone diseasemedicine.medical_treatmentDifosfonatosDentistryCase Report:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Peri-implantitisDental implant:Chemicals and Drugs::Organic Chemicals::Organophosphorus Compounds::Diphosphonates [Medical Subject Headings]Implantes dentales:Anatomy::Cells::Connective Tissue Cells::Macrophages::Osteoclasts [Medical Subject Headings]ImidazolesOsteonecrosisBisphosphonates:Diseases::Neoplasms [Medical Subject Headings]:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludNeoplasiasHumanosmedicine.anatomical_structureNeoplasias de la mama:Chemicals and Drugs::Biomedical and Dental Materials::Dental Materials::Dental Implants [Medical Subject Headings]UNESCO::CIENCIAS MÉDICASMaxillectomy:Diseases::Stomatognathic Diseases::Mouth Diseases::Peri-Implantitis [Medical Subject Headings]Oral SurgeryResorción óseamedicine.drugmedicine.medical_specialtyOdontología:Diseases::Musculoskeletal Diseases::Bone Diseases::Osteonecrosis [Medical Subject Headings]Bone resorptionBreast cancerOsteoclast:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Azoles::Imidazoles [Medical Subject Headings]medicinePeriimplantitisGeneral DentistryZoledronic acid:Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings]Osteonecrosis of the jawbusiness.industry:Phenomena and Processes::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Musculoskeletal Physiological Processes::Bone Remodeling::Bone Resorption [Medical Subject Headings]Osteoclastosmedicine.diseaseSurgeryZoledronic acid:Check Tags::Female [Medical Subject Headings]Osteonecrosis of the jawbusinessJournal of Clinical and Experimental Dentistry
researchProduct